| Drug Name: | gd-dtpa-bma (131410-48-5) |
|---|---|
| PubChem ID: | 153921 |
| SMILES: | CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] |
| InchiKey: | HZHFFEYYPYZMNU-UHFFFAOYSA-K |
| Therapeutic Category: | Contrast Media |
| Molecular Weight (dalton) | : | 573.661 |
| LogP | : | -7.3659 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 11 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 188.31 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Migraine Aggravated | SIDER |
| Multiple Sclerosis | SIDER |
| Nephrogenic Systemic Fibrosis | SIDER |